Test article for QA
By Amit Mehta, Eduardo Gallardo, Robert W. Leung, Jason M. Rednour, Jessamy Gallagher, and Paul Hastings on December 15, 2023
Article for testing purposes header 1 header 2 header 3 test .bold underlined a everything subscriptdf s superscriptdfd italicized abcdefghijklmnopqrstuvwxyz words with r refreshed rrrrrrrrrrrsdfadf ...
FPO: Federal Court Dismisses Derivative Complaint Seeking to Impose ESG Initiatives on a Public Company
By Jessamy Gallagher on September 30, 2018
In the past year, there has been a concerted effort by certain plaintiff firms to weaponize environmental, social, and governance (“ESG”) principles to attack corporate boards. On March 19, 2021, the United States District Court for the Northern District of California in Ocegueda v. Zuckerberg, Ca. No. 3:20-cv-04444-LB (N.D. Cal. Mar. 19, 2021), struck a blow against these efforts by granting defendants’ motion to dismiss.
FPO: First of Its Kind – SEC Settles Charges Against Public Company for Misleading COVID-19 Related Disclosures
By Amit Mehta on September 29, 2018
On December 4, 2020, the Securities and Exchange Commission announced the settlement of its first ever enforcement action against a public company for misleading COVID-19 related disclosures.
FPO: Chinese Public Companies Confront the Risk of Delisting from U.S. Securities Exchanges
By Jessamy Gallagher and Jason M. Rednour on September 28, 2018
On December 2, 2020, with a bipartisan voice vote, the House approved Senate Bill S. 945 to enact the Holding Foreign Companies Accountable Act (the “Act”).
FPO: Watching the Backdoor: Planning for and Responding to a Cybersecurity Incident at Medical Device Companies – An FDA Perspective
By Robert W. Leung on September 27, 2018
Much has been written this year related to how the ongoing COVID-19 pandemic has impacted medical device companies, including business disruptions, product shortages, and other challenges.
FPO: Jasper Therapeutics to Merge with Amplitude Healthcare Acquisition Corporation to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
By Jason M. Rednour on September 26, 2018
FPO: Palo Alto – Paul Hastings LLP, a leading global law firm, announced today that the firm served as legal advisor to Jasper Therapeutics, Inc. (Jasper Therapeutics) in its agreement to merge with A...